I agree that this site is using cookies. You can find further informations here.
X
Poder, Airi
28  results:
Search for persons X
?
1

A Phase III, multicenter, randomized, double-blind, active ..:

Martinon-Torres, Federico ; Wysocki, Jacek ; Szenborn, Leszek...
Vaccine.  41 (2023)  21 - p. 3387-3398 , 2023
Link: https://doi.org/10.1016/..
 
?
2

Immunogenicity and safety of the non-typableHaemophilus inf..:

Galgani, Ilaria ; Põder, Airi ; Jõgi, Rain...
Human Vaccines & Immunotherapeutics.  19 (2023)  1 - p. , 2023
Link: https://doi.org/10.1080/..
 
?
3

Immunogenicity and Safety of MF59-Adjuvanted Quadrivalent I..:

Poder, Airi ; Oberije, Janine ; Meyer, Jay...
Vaccines.  11 (2023)  10 - p. 1528 , 2023
Link: https://doi.org/10.3390/..
 
?
4

Respiratory Syncytial Virus Disease Burden in Community-Dwe..:

Narejos Pérez, Sílvia ; Ramón Torrell, Josep María ; Põder, Airi...
Open Forum Infectious Diseases.  10 (2023)  4 - p. , 2023
Link: https://doi.org/10.1093/..
 
?
5

Immunological non-inferiority of a new fully liquid present..:

Díez-Domingo, Javier ; Tinoco, Juan Carlos ; Poder, Airi...
Human Vaccines & Immunotherapeutics.  18 (2021)  1 - p. , 2021
Link: https://doi.org/10.1080/..
 
?
6

Corrigendum to 'Immunogenicity and safety of the adjuvanted..:

Maréchal, Céline ; Lal, Himal ; Poder, Airi...
Vaccine.  37 (2019)  9 - p. 1252-1253 , 2019
Link: https://doi.org/10.1016/..
 
?
7

Immunogenicity, reactogenicity and safety of 2 doses of an ..:

Lal, Himal ; Poder, Airi ; Campora, Laura...
Vaccine.  36 (2018)  1 - p. 148-154 , 2018
Link: https://doi.org/10.1016/..
 
?
8

MenACWY-TT is immunogenic when co-administered with Tdap an..:

Rivera, Luis ; Chanthavanich, Pornthep ; Põder, Airi...
Vaccine.  36 (2018)  27 - p. 3967-3975 , 2018
Link: https://doi.org/10.1016/..
 
?
9

165 Apremilast, an oral phosphodiesterase-4 inhibitor, is a..:

Mease, Philip J ; Marzo-Ortega, Helena ; Poder, Airi...
Rheumatology.  57 (2018)  suppl_3 - p. , 2018
Link: https://doi.org/10.1093/..
 
?
10

Immunogenicity and safety of the adjuvanted recombinant zos..:

Maréchal, Céline ; Lal, Himal ; Poder, Airi...
Vaccine.  36 (2018)  29 - p. 4278-4286 , 2018
Link: https://doi.org/10.1016/..
 
?
11

Immunogenicity and Safety of 2 Doses of an Investigational ..:

Poder, Airi ; Geeraerts, Brecht ; Lal, Himal...
Open Forum Infectious Diseases.  3 (2016)  suppl_1 - p. , 2016
Link: https://doi.org/10.1093/..
 
?
12

Efficacy of an Adjuvanted Herpes Zoster Subunit Vaccine in ..:

Cunningham, Anthony L ; Chlibek, Roman ; Diez-Domingo, Javier...
Open Forum Infectious Diseases.  2 (2015)  suppl_1 - p. , 2015
Link: https://doi.org/10.1093/..
 
?
13

An observer-blind, randomized, multi-center trial assessing..:

Poder, Airi ; Simurka, Pavol ; Li, Ping..
Vaccine.  32 (2014)  9 - p. 1121-1129 , 2014
Link: https://doi.org/10.1016/..
 
?
14

HIV in Europe:

Põder, Airi ; Haldre, Madli
Clinics in Dermatology.  32 (2014)  2 - p. 282-285 , 2014
Link: https://doi.org/10.1016/..
 
?
15

Long‐term persistence of systemic and mucosal immune respon..:

Petäjä, Tiina ; Pedersen, Court ; Poder, Airi...
International Journal of Cancer.  129 (2011)  9 - p. 2147-2157 , 2011
Link: https://doi.org/10.1002/..
 
1-15